Compare RCAT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCAT | VALN |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 957.4M | 820.0M |
| IPO Year | 2017 | 2021 |
| Metric | RCAT | VALN |
|---|---|---|
| Price | $7.41 | $8.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $12.50 | ★ $15.75 |
| AVG Volume (30 Days) | ★ 6.9M | 20.4K |
| Earning Date | 12-16-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,443,942.00 | ★ $211,089,992.00 |
| Revenue This Year | $396.50 | $5.08 |
| Revenue Next Year | $296.06 | $12.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.48 |
| 52 Week Low | $4.58 | $3.62 |
| 52 Week High | $16.70 | $12.25 |
| Indicator | RCAT | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 37.87 |
| Support Level | $8.01 | $8.62 |
| Resistance Level | $8.80 | $9.10 |
| Average True Range (ATR) | 0.60 | 0.30 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 31.72 | 0.76 |
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.